CA
NZ
UK
AU
IND
US
Cryo-Cell International, Inc. (NYSE American:CCEL) rose sharply on Friday, October 16, 2026, closing at $4.420, a gain of 21.10% for the session. The move stood out against a weaker broad market, where the Nasdaq Composite fell 2.14% and the S&P 500 slipped 1.09% amid …
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a micro-cap biotechnology company, finished among the day’s gainers in a session that was otherwise defined by broad market weakness, closing at $4.52, up 4.39% on Friday, October 16, 2026.
CytoSorbents Corporation (NASDAQ:CTSO) was a notable gainer in the US session on Friday, October 16, 2026, closing at $4.110, up 34.31%. The move came on a day marked by a sharp selloff in technology, artificial-intelligence and semiconductor shares, with the Nasdaq Composite down 2.14% …
● Goldman Sachs and Jefferies led the deal.
Upstream Bio Inc. (NASDAQ:UPB) shares closed Friday, October 16, 2026, at $2.76, down 18.10% on the day, a decline that ranked the clinical-stage biotech among the session’s largest percentage losers. No company-specific news was confirmed for Upstream Bio on October 16, so the move …
SCWorx Corp. (NASDAQ:WORX) ended Friday’s US session sharply lower, closing at $1.380 for a decline of 31.34% on the day. The drop placed the healthcare data-services micro-cap among the session’s worst performers and continued the kind of outsized volatility that is characteristic of small, …
YD Bio Limited (NASDAQ:YDES), a micro-cap biotechnology company, closed Friday, October 16, 2026, at $5.92, down 12.17% on the session. The decline came during a broadly negative day for US equities in which biotechnology shares came under pressure and smaller, lightly traded names moved …
SkinHealth Systems Inc. (NASDAQ:SKIN), formerly The Beauty Health Company, closed Friday, October 16, 2026, at $10.56, down 16.19% on the day, a decline that put the small-cap consumer health name among the session’s largest percentage losers. No company-specific news was confirmed for SkinHealth Systems …
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), a clinical-stage biotechnology company, closed Friday, October 16, 2026, at $9.98, down 11.99% on the session. The decline came on a day when risk appetite contracted across the market and biotechnology shares came under broad pressure. No company-specific …
Novavax, Inc. (NASDAQ:NVAX), the vaccine-focused biotechnology company, closed Friday, October 16, 2026, at $11.26, down 12.17% on the session. The decline came on a day when risk appetite drained out of the market and biotechnology shares came under broad pressure. No company-specific news has …
Please wait processing your request...